Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
McKinsey
Accenture
Express Scripts
Argus Health
Teva
Healthtrust
Covington

Generated: April 19, 2018

DrugPatentWatch Database Preview

MEPIVACAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Mepivacaine Hydrochloride, and what generic alternatives are available?

Mepivacaine Hydrochloride is a drug marketed by Belmora Llc, Hospira Inc, Intl Medication Sys, and Watson Labs. and is included in six NDAs.

The generic ingredient in MEPIVACAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Drug patent expirations by year for MEPIVACAINE HYDROCHLORIDE
Synonyms for MEPIVACAINE HYDROCHLORIDE
(+-)-1-Methyl-2',6'-pipecoloxylidide monohydrochloride
(+/-)-Mepivacaine hydrochloride, >=98% (HPLC)
(1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride
(1-methyl-dl-piperidine-2-carboxylicacid)-2,6-dimethylanilidehydrochloride
1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
1-Methyl-2 inverted exclamation marka,6 inverted exclamation marka-pipecoloxylidine hydrochloride
1-Methyl-2',6'-pipecoloxylidide hydrochloride
1-Methyl-2',6'-pipecoloxylidide monohydrochloride
1-Methyl-2',6'-pipecoloxylidine hydrochloride
16452-56-5
1722-62-9
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride, (+-)-
2',6'-Pipecoloxylidide, 1-methyl -, monohydrochloride
38423-99-3
6 inverted exclamation mark -pipecoloxylidide,1-methyl-2monohydrochloride
722M629
96-88-8 (Parent)
A811391
AB0012058
AC-2102
AC1L24K2
ACT02686
AK-61115
AKOS015889311
AN-14290
ANW-46921
API0003297
Arestocaine hydrochloride
AX8032267
BC220537
BG0250
BR-61115
C-17796
Carbocaina
Carbocaine (TN)
Carbocaine hydrochloride
Carbocaine monohydrochloride
carbocainehydrochloride
CAS-1722-62-9
CC-30208
CCG-101083
CCG-39081
CHEBI:6760
CHEMBL1200440
Chlorocain
CPD000058904
CS-2729
CTK8B4971
D00738
dl-1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
dl-mepivacainehydrochloride
DSSTox_CID_11566
DSSTox_GSID_31566
DSSTox_RID_78885
DTXSID4031566
EINECS 217-023-9
FT-0080089
FT-0601566
HE222297
HMS1922D17
HY-B0517A
I01-1865
ISOCAINE HYDROCHLORIDE
KS-00001F7F
KS-1271
LS-2120
M2560
MCULE-4459584385
Meaverin
Mepicaton
Mepident
mepivacain hydrochloride
Mepivacaine (hydrochloride)
Mepivacaine chlorhydrate
Mepivacaine HCL
Mepivacaine hydrochloride (JP17/USP)
Mepivacaine hydrochloride [USAN:JAN]
Mepivacaine hydrochloride [USP:JAN]
Mepivacaine hydrochloride, 98.0-102.0%, meets USP testing specifications
Mepivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Mepivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Mepivacaine Monohydrochloride
Mepivacaine(hydrochloride)
MepivacaineHCL//Mepivacaine
Mepivastesin
Mepivicaine hydrochloride
MEPIVICAINE HYDROCHLORIDE (MEPIVICAINE (96-88-8))
MFCD00144738
MLS000028662
MLS001074068
MLS001424226
MolPort-003-666-532
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide hydrochloride
n-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamidmonohydrochloride
N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1)
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamidehydrochloride
N-(2,6-dimethylphenyl)(1-methyl(2-piperidyl))carboxamide, chloride
NC00333
NCGC00095108-01
NCGC00095108-02
NCGC00095108-03
NSC-758674
NSC758674
Opera_ID_1165
Optocain
Pharmakon1600-01504148
Polocaine (TN)
Q-201354
RETIMRUQNCDCQB-UHFFFAOYSA-N
S-6505
s3155
Sabol
SAM001246875
SBB057000
SC-13935
Scandinibsa
Scandonest
Scandonest Plain
Scandonest plain (TN)
SCHEMBL34245
SMR000058904
SPECTRUM1504148
ST2419639
ST50993897
TC-135666
Tox21_111424

US Patents and Regulatory Information for MEPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belmora Llc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 083559-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 088769-001 Nov 20, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 040806-001 Apr 28, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Intl Medication Sys MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 087509-001 Oct 5, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Colorcon
Cipla
Argus Health
Cerilliant
Covington
QuintilesIMS
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.